Healthcare · NSE: NEPHROPLUS
Nephrocare Health Services Limited
₹628.40
-0.98% · close 28 Oct 2026
52-week range
₹449.15 – ₹765.35
From 52W high
-17.89%
Return 1Y
—
Volume · Avg 20D
59,025 · 2.03 L
Returns & technicals
1W+3.20%
1M-9.80%
3M-8.90%
6M+16.66%
1Y—
| 50-day average | ₹677.07 below |
| 200-day average | ₹616.70 above |
| Volatility (1Y, annualised) | 40.54% |
| RSI (14) | 44.3 |
| MACD histogram (12, 26, 9) | 3.24 |
| Delivery · 20D avg | 43.22% · 53.96% |
| Turnover (last day) | ₹4 Cr |
Profile
| Symbol | NEPHROPLUS |
| ISIN | INE428V01029 |
| Sector | Healthcare |
| Listed on NSE | 17 Dec 2025 |
| Face value | ₹2 |
| Series | EQ |
Financials & shareholding
Quarterly results, P/E and the shareholding pattern for NEPHROPLUS are coming in a later update.
Peers in Healthcare
| Stock | Price | Day | 1M | 1Y |
|---|---|---|---|---|
| PPLPHARMA Piramal Pharma Limited | ₹232.80 | +17.15% | +10.69% | +15.19% |
| SYNGENE Syngene International Limited | ₹410.85 | +12.19% | +8.49% | -37.51% |
| ACUTAAS Acutaas Chemicals Limited | ₹3,710.00 | -2.20% | +13.37% | +116.38% |
| DIVISLAB Divi's Laboratories Limited | ₹9,558.50 | +0.56% | -0.63% | +48.46% |
| ONESOURCE Onesource Specialty Pharma Limited | ₹1,577.60 | -0.77% | -1.56% | -14.00% |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137.00 | +4.43% | -8.46% | +3.25% |